Norbert Bischofberger, Ph.D.

President & Chief Executive Officer

Norbert joined Gilead Sciences in 1990 and served as Head of Research beginning in 1994, Executive Vice President for Research and Development from 1999 to 2018 and Chief Scientific Officer from 2007 to 2018. Prior to joining Gilead, Norbert was a Senior Scientist in Genentech’s DNA Synthesis Group from 1986 until 1990.

Norbert received a Ph.D. in organic chemistry from Zurich’s Eidgenössische Technische Hochschule and performed postdoctoral research in steroid chemistry at Syntex. He also performed additional research in organic chemistry and applied enzymology in Professor George Whiteside’s lab at Harvard University in Cambridge, Massachusetts.